Get started
Author

Toshihisa Tomoda

Observed names: T Tomoda, TOSHIHISA TOMODA
ORCID: 0000-0002-9346-1900
Observed ORCID: 0000-0002-9346-1900
OpenAlex ID: A5073793517
RhoA/Rho kinase‐mediated Ca2+ sensitization in the contraction of human prostate
2007 · Ryosuke Takahashi, Junji Nishimura, et al. · Neurourology and Urodynamics · 40
Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate
2007 · Narihito Seki, Takakazu Yunoki, et al. · Neurourology and Urodynamics · 36
Site-specific Response to Nivolumab in Renal Cell Carcinoma
2021 · TAKAHITO NEGISHI, NOBUKI FURUBAYASHI, et al. · Anticancer Research · 30
PDF
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab
2021 · Nobuki Furubayashi, Akinori Minato, et al. · Cancer Management and Research · 25
PDF
Actions of ZD0947, a novel ATP‐sensitive K+channel opener, on membrane currents in human detrusor myocytes
2006 · M Aishima, T Tomoda, et al. · British Journal of Pharmacology · 22
PDF
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study
2022 · Akinori Minato, Nobuki Furubayashi, et al. · Clinical Genitourinary Cancer · 21
PDF
Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy
2024 · AKINORI MINATO, NOBUKI FURUBAYASHI, et al. · Anticancer Research · 18
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study
2024 · Akinori Minato, Nobuki Furubayashi, et al. · Current Oncology · 18
PDF
Treating Japanese Patients With Pembrolizumab for Platinum-Refractory Advanced Urothelial Carcinoma in Real-World Clinical Practice
2020 · Nobuki Furubayashi, Kentaro Kuroiwa, et al. · Journal of Clinical Medicine Research · 18
PDF
The effects of flavoxate hydrochloride on voltage‐dependent L‐type Ca2+ currents in human urinary bladder
2005 · Toshihisa Tomoda, Manami Aishima, et al. · British Journal of Pharmacology · 17
PDF
Cutaneous and Renal Toxicities of Enfortumab Vedotin for Advanced Urothelial Carcinoma: The UROKYU Study
2024 · NOBUKI FURUBAYASHI, AKINORI MINATO, et al. · Anticancer Research · 15
Predictive factors of late biochemical recurrence after radical prostatectomy
2016 · Takahito Negishi, Kentarou Kuroiwa, et al. · Japanese Journal of Clinical Oncology · 15
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab
2022 · Nobuki Furubayashi, Akinori Minato, et al. · Cancer Management and Research · 14
PDF
Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy
2021 · Nobuki Furubayashi, Takahito Negishi, et al. · OncoTargets and Therapy · 14
PDF
Comparative studies of ZD0947, a novel ATP-sensitive K+ channel opener, on guinea pig detrusor and aortic smooth muscles
2007 · Takakazu Yunoki, Hai-Lei Zhu, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 13
Different glibenclamide-sensitivity of ATP-sensitive K+ currents using different patch-clamp recording methods
2006 · Noriyoshi Teramoto, Toshihisa Tomoda, et al. · European Journal of Pharmacology · 13
Organ-Specific Tumor Response to Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study
2024 · Akinori Minato, Nobuki Furubayashi, et al. · Clinical Genitourinary Cancer · 12
PDF
Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study
2020 · Masaki Shiota, Motonobu Nakamura, et al. · Anti-Cancer Drugs · 11
Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study
2019 · Masaki Shiota, Motonobu Nakamura, et al. · Medical Oncology · 10
Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study
2020 · Takashi Matsumoto, Masaki Shiota, et al. · Prostate International · 9
PDF
The actions of azelnidipine, a dihydropyridine‐derivative Ca antagonist, on voltage‐dependent Ba2+ currents in guinea‐pig vascular smooth muscle
2006 · H‐L Zhu, T Tomoda, et al. · British Journal of Pharmacology · 9
Paclitaxel and carboplatin chemotherapy after platinum‑based chemotherapy and pembrolizumab for metastatic urothelial carcinoma
2021 · Nobuki Furubayashi, Yoshifumi Hori, et al. · Molecular and Clinical Oncology · 7
PDF
Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study
2019 · Masaki Shiota, Motonobu Nakamura, et al. · Cancer Chemotherapy and Pharmacology · 7
Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra
2005 · Toshihisa Tomoda, Takakazu Yunoki, et al. · European Journal of Pharmacology · 7
Organ-specific Tumor Response to Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma: A Multicenter Retrospective Study
2023 · NOBUKI FURUBAYASHI, AKINORI MINATO, et al. · Anticancer Research · 6
Works count: 44
Citation count: 457
H-index: 14
I10-index: 19
Year
Topic
Type